CLINICAL_TRIALS
trial_result
· 2011-07-11
Clinical Trial Update: AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia [Phase 4]
Summary
This entry provides an update on the AIDA2000 Phase 4 trial evaluating risk-adapted therapy for acute promyelocytic leukemia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Technische Universität Dresden | Conditions: Leukemia, Promyelocytic, Acute | Phase 4 | Status: UNKNOWN